Skip to main content
lexblog.com/lib/4CCS9J9Eviewrecordjson
LEX-WK-4CCS9J9Ecrawled 2021-11-02 10:22Z

FDA’s Section 804 Prescription Drug Importation Program and 801(d)(1)(B) Guidance

Kevin Madagan · Cori Annapolen Goldberg · Sung Park · Catherine David · Life Sciences Legal Update · Published January 14, 2020

Work details

firm or organization
Reed Smith LLP
published
2020-01-14

Citation

Kevin Madagan, Cori Annapolen Goldberg, Sung Park, Catherine David, FDA’s Section 804 Prescription Drug Importation Program and 801(d)(1)(B) Guidance, Life Sciences Legal Update (January 14, 2020) [The Library at LexBlog, LEX-WK-4CCS9J9E, lexpid.org/4CCS9J9E]